NPI: 1114931052 · MONTEBELLO, CA 90640 · Optometrist · NPI assigned 07/28/2006
Authorized official KELLY, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | KELLY, MARK (MEMBER, BOARD OF MANAGERS) |
| NPI Enumeration Date | 07/28/2006 |
Other providers sharing the same authorized official: KELLY, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 55,985 | $1.24M |
| 2019 | 71,747 | $2.09M |
| 2020 | 50,766 | $1.57M |
| 2021 | 89,155 | $2.63M |
| 2022 | 124,887 | $3.89M |
| 2023 | 111,221 | $4.16M |
| 2024 | 92,631 | $3.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 22,529 | 21,076 | $3.90M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 6,331 | 5,364 | $3.14M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 76,999 | 75,136 | $1.94M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 45,214 | 45,160 | $1.33M |
| J9035 | Injection, bevacizumab, 10 mg | 16,867 | 15,869 | $1.26M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 42,252 | 42,136 | $1.09M |
| 92134 | 65,406 | 53,311 | $832K | |
| V2020 | Frames, purchases | 54,089 | 54,004 | $750K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13,030 | 13,022 | $613K |
| 92133 | 33,813 | 29,740 | $563K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 39,434 | 39,376 | $508K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13,511 | 13,103 | $407K |
| 92083 | 23,234 | 23,072 | $402K | |
| 92015 | Determination of refractive state | 72,002 | 71,899 | $362K |
| 92341 | 12,967 | 12,948 | $241K | |
| 92226 | 6,414 | 6,210 | $184K | |
| 92250 | 7,258 | 6,519 | $158K | |
| 68761 | 1,413 | 1,156 | $125K | |
| 92202 | 12,594 | 11,948 | $111K | |
| 67210 | 374 | 354 | $94K | |
| 67228 | 441 | 397 | $84K | |
| 66761 | 558 | 406 | $82K | |
| 92201 | 5,943 | 5,852 | $78K | |
| J7999 | Compounded drug, not otherwise classified | 3,264 | 3,094 | $74K |
| 76519 | 2,020 | 1,797 | $56K | |
| 92225 | 1,548 | 1,520 | $52K | |
| 92136 | 1,355 | 1,294 | $51K | |
| 92020 | 4,262 | 4,242 | $46K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,281 | 2,280 | $44K |
| 76514 | 5,081 | 5,057 | $30K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,100 | 1,076 | $25K |
| 67145 | 80 | 78 | $23K | |
| 92025 | 1,381 | 1,286 | $23K | |
| 66982 | 32 | 28 | $22K | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 509 | 292 | $20K |
| 65855 | 120 | 109 | $15K | |
| 92235 | 231 | 219 | $14K | |
| 76512 | 202 | 184 | $5K | |
| 99215 | Prolong outpt/office vis | 24 | 24 | $1K |
| 99243 | 147 | 147 | $1K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 14 | 14 | $384.00 |
| V2744 | Tint, photochromatic, per lens | 12 | 12 | $292.74 |
| 92285 | 31 | 26 | $271.19 | |
| 99422 | 25 | 25 | $155.20 |